Network origin in Eric A. Emery first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Protein Design Labs, Inc.
 Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products.
34
| Extinct | Pharmaceuticals: Major | 34 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Eric A. Emery via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| PDL BIOPHARMA, INC. | Biotechnology | Founder Founder Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Chairman Chief Tech/Sci/R&D Officer Human Resources Officer Sales & Marketing President Chief Executive Officer Chief Executive Officer Corporate Officer/Principal Chairman General Counsel Director/Board Member Comptroller/Controller/Auditor General Counsel Corporate Officer/Principal General Counsel General Counsel Public Communications Contact | |
| The University of Chicago | College/University | Undergraduate Degree Graduate Degree Doctorate Degree Masters Business Admin | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Comptroller/Controller/Auditor Corporate Officer/Principal Corporate Officer/Principal | |
| Stanford University | College/University | Corporate Officer/Principal Graduate Degree Undergraduate Degree | |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal President Corporate Officer/Principal | |
| CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Compliance Officer Chairman General Counsel | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
| ONCOMED PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| DURECT CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
EOS Biotechnology, Inc.
 EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology EOS Biotechnology, Inc. develops therapeutic and diagnostic drugs. The company was founded by Herbert L. Heyneker, John Lowe, David H. Mack, David W. Martin, Richard Murray, and Stephen W. Weiss and is headquartered in Fermont, California. | Pharmaceuticals: Major | Founder Corporate Officer/Principal | |
Stellular Bio, Inc.
 Stellular Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Stellular Bio, Inc. develops technology to produce independent human platelets from human induced pluripotent stem cells. The company was founded by Jonathan Thon, Joseph Italiano and Sven Karlsson in 2014 and is headquartered in Watertown, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Pharmaceuticals: Major | Comptroller/Controller/Auditor Corporate Officer/Principal | |
Genaissance Pharmaceuticals, Inc.
 Genaissance Pharmaceuticals, Inc. BiotechnologyHealth Technology Genaissance Pharmaceuticals, Inc. develops and uses genetic information to diagnostic and therapeutic products. The company was founded by Kevin L. Rakin and Gualberto Ruano in 1992 and is headquartered in New Haven, CT. | Biotechnology | Director/Board Member Chairman | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| SORRENTO THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| New York University School of Law | College/University | Graduate Degree Graduate Degree | |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Director/Board Member Director/Board Member | |
| LADRX CORPORATION | Biotechnology | Corporate Officer/Principal Chairman | |
| CYTOKINETICS, INCORPORATED | Pharmaceuticals: Major | Director/Board Member Chairman | |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Biotechnology | Founder Director/Board Member | |
Sandoz Ltd.
 Sandoz Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Sandoz Ltd. is a British company that develops, produces and markets medicines. The company is based in Camberley, UK and was founded in 1981. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Sales & Marketing Chief Tech/Sci/R&D Officer | |
Roche Diagnostics GmbH
 Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Operating Officer | |
| The Johns Hopkins University | College/University | Graduate Degree Undergraduate Degree | |
| EXELIXIS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| The University of North Carolina at Charlotte | College/University | Corporate Officer/Principal Doctorate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Sales & Marketing | |
| ACUCELA INC | Pharmaceuticals: Major | Director/Board Member | |
Azelon Pharmaceuticals, Inc.
 Azelon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Azelon Pharmaceuticals, Inc. develops biopharmaceutical drugs for the treatment of osteoporosis. It develops parathyroid hormone analogs for the treatment of bone diseases, which are characterized by deficits in bone formation, including osteoporosis, orthopedic conditions and renal bone disease. The company was founded by Paul Morley and Godfrey Marchand in 2000 and is headquartered in West Conshohocken, PA. | Pharmaceuticals: Major | President | |
San Francisco Chronicle
 San Francisco Chronicle Publishing: NewspapersConsumer Services Part of The Hearst Family Trust, San Francisco Chronicle is a daily newspaper publisher. The company is based in San Francisco, CA. San Francisco Chronicle was acquired by The Hearst Corp. from Chronicle Publishing Co. on July 27, 2000 for $660 million. The company was founded in 1865. The CEO is Bill Nagel. | Publishing: Newspapers | Corporate Officer/Principal | |
| PHARMCHEM, INC. | Services to the Health Industry | Corporate Officer/Principal | |
| University of Oklahoma | College/University | Masters Business Admin | |
Pulmatrix Operating Co., Inc.
 Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Pulmatrix Operating Co., Inc. develops pharmaceutical products for respiratory infectious diseases. Its iSPERSE powders can be used with an array of dry powder inhaler technologies and can be formulated with virtually any drug substance. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov and Robert S. Langer in 2003 and is headquartered in Lexington, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Indiana University | College/University | Masters Business Admin | |
| Rose-Hulman Institute of Technology, Inc. | College/University | Undergraduate Degree | |
Vida Ventures LLC
 Vida Ventures LLC Investment ManagersFinance Vida Ventures LLC invests in companies located in the United States. The fund targets companies operating in the fields of life science innovation. It provides financing for seed, early and later stage capital requirements. | Investment Managers | Corporate Officer/Principal | |
VV Manager LLC
 VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
US News & World Report LP
 US News & World Report LP Publishing: NewspapersConsumer Services U.S. News & World Report LP publishes newspapers and magazines. It publishes information related to politics, money, business, education, colleges, health and hospitals as well as places to work in the federal government. The company was founded by David Lawrence in 1933 and is headquartered in New York City, NY. | Publishing: Newspapers | Corporate Officer/Principal | |
| The University of Chicago Booth School of Business | College/University | Graduate Degree | |
University of Akron
 University of Akron Other Consumer ServicesConsumer Services University of Akron provides public research education. Its programs include under graduate studies, graduate studies, international studies, law, and continuing education. The company was founded in 1870 and is headquartered in Akron, OH. | College/University | Graduate Degree | |
Celularity, Inc. (United States)
 Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Celularity, Inc. engages in biotechnology company. The firm focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in Florham Park, NJ. | Miscellaneous Commercial Services | Director/Board Member | |
Semnur Pharmaceuticals, Inc.
 Semnur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Semnur Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The firm focuses on the clinical and commercial development of products such as SP-102: a non-opioid epidural steroid injectable potentially for the treatment of Lumbosacral radicular pain. The company was founded by Mahendra G. Shah in 2013 and is headquartered in Mountain View, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
| University of St. Gallen | College/University | Doctorate Degree |
Statistics
International
| United States | 48 |
| United Kingdom | 2 |
| Germany | 2 |
| Switzerland | 2 |
Sectoral
| Health Technology | 30 |
| Consumer Services | 16 |
| Commercial Services | 4 |
| Finance | 3 |
| Health Services | 2 |
Operational
| Director/Board Member | 151 |
| Corporate Officer/Principal | 88 |
| Chairman | 40 |
| Independent Dir/Board Member | 35 |
| Chief Tech/Sci/R&D Officer | 29 |
Most connected contacts
| Insiders | |
|---|---|
| Jon Saxe | 43 |
| Mark McDade | 35 |
| Helen Kim | 34 |
| Max E. Link | 28 |
| Leonard Patrick Gage | 26 |
| Karen Dawes | 22 |
| Samuel Broder | 18 |
| Jaisim Shah | 17 |
| George T. Jue | 15 |
| Barbara Finck | 15 |
| George M. Gould | 13 |
| Steven E. Benner | 13 |
| Laurie C. Torres | 11 |
| Fred Kurland | 11 |
| Richard Murray | 10 |
- Stock Market
- Insiders
- Eric A. Emery
- Company connections
